Canada Diabetes Market Report: 2016 – 2020

1. Imarc www.imarcgroup.com Consulting Services Canada Diabetes Market Report 2016 - Trends, Developments, Forecasts, Analysis and Overview Copyright © 2016International Market Analysis Research & Consulting (IMARC). All Rights Reserved

2. Imarc www.imarcgroup.com About IMARC Group The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Imarc www.imarcgroup.com Report Description and Highlights • Canada Diabetes Market Report 2016 - Trends, Developments, Forecasts, Analysis and Overview • This report provides an insight into the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the diabetes market (insulin and oral antidiabetics) in Canada. • IMARC’s new report “Canada Diabetes Market Report: 2016 - 2020” provides an analytical and statistical insight into the Canada diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Canada. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Canada diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Canada diabetes market in any form. • What we have achieved in this report: • Comprehensive situation analysis of the Canada diabetes epidemiology and its dynamics: • Focus of the Analysis: • Historical, current and future prevalence of diabetes in Spain

4. Imarc www.imarcgroup.com Report Description and Highlights • Historical, current and future prevalence of type-1 and type-2 diabetes in Canada • Historical, current and future prevalence of diabetes in the urban and rural regions in Canada • Historical, current and future prevalence of diabetes among males and females in Canada • Historical, current and future prevalence of diabetes among various age groups in Canada • Historical, current and future diagnosis rates for diabetes in Canada • Historical, current and future drug treatment rates for diabetes in Canada • Comprehensive situation analysis of the Canadian Oral Antidiabetics market and its dynamics: • Focus of the Analysis: • Performance of the Oral Antidiabetics market in Canada • Performance of key classes • Performance of key players • Market outlook • Comprehensive situation analysis of the Canadian Insulin market and its dynamics: • Focus of the Analysis: • Performance of the Insulin market in Canada • Performance of key classes • Performance of key players • Market outlook

5. Imarc www.imarcgroup.com Germany Diabetes Market

6. Imarc www.imarcgroup.com Report Description and Highlights Table of Contents 1 Research Methodology2 Executive Summary3 Diabetes Disease Overview3.1 What is Diabetes?3.2 Diabetes Diagnosis and Treatment3.2.1 Diagnosis3.2.2 Treatment3.3 Diabetes Complications4 Key Factors Driving the Diabetes Market in Canada5 Canada Diabetes Epidemiology5.1 Diabetes Population and Prevalence Rates5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)5.3 Population and Prevalence Rates by Region5.4 Population and Prevalence Rates by Gender5.5 Population and Prevalence Rates by Age Group6 Canada Diabetes Market6.1 Historical Market Trends6.2 Market Outlook6.3 Market Breakup by Segment

7. Imarc www.imarcgroup.com Report Description and Highlights 6.4 Canada Oral Antidiabetics Market6.4.1 Historical Market Trends6.4.2 Market Breakup by Class6.4.3 Market Shares of Key Players6.4.4 Market Outlook6.5 Canada Insulin Market6.5.1 Historical Market Trends6.5.2 Market Breakup by Class6.5.3 Market Shares of Key Players6.5.4 Market Outlook List of Figures Figure 3 1: The impact of Diabetes in the Human BodyFigure 3 2: Diabetes ComplicationsFigure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 & 2035Figure 4 2: Canada: Overweight & Obese Population* (in Million), 2010, 2015 & 2020Figure 4 3: Body Mass Index and Relative risk of Type-2 DiabetesFigure 4 4: Canada: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)Figure 4 5: Canada: Diabetes Prevalence By Age Groups, (in %)Figure 5 1: Canada: Total Number of Diabetes Patients* (in 000), 2008-2015Figure 5 2: Canada: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020Figure 5 3: Canada (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015

8. Imarc www.imarcgroup.com Report Description and Highlights Figure 5 4: Canada (Type1 & Type2): Total Number of Diabetes Patients* (in 000),2016-2020Figure 5 5: Canada (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2008 -2015Figure 5 6: Canada (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2016 - 2020Figure 5 7: Canada (Male & Female): Total Number of Diabetes Patients* (in 000), 2008 - 2015Figure 5 8: Canada (Male & Female): Total Number of Diabetes Patients* (in 000), 2016 - 2020Figure 5 9: Canada: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2008 - 2015Figure 5 10: Canada: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2016 - 2020Figure 6 1: Canada: Diabetes Drugs Market (in Million US$), 2008 - 2015Figure 6 2: Canada: Diabetes Drug Market Forecast (in Million US$), 2016 - 2020Figure 6 3: Canada: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2008 - 2015Figure 6 4: Canada: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016 - 2020Figure 6 5: Canada: Oral Antidiabetics Market: (in Million US$), 2008 - 2015Figure 6 6: Canada: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008 & 2015Figure 6 7: Canada: Oral Anti-diabetics Market: Sales Share of Key Players (in %)Figure 6 8: Canada: Oral Antidiabetics Market: (in Million US$), 2016 - 2020Figure 6 9: Canada: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 & 2020Figure 6 10: Canada: Insulin Market, (in Million US$), 2008 - 2015Figure 6 11: Canada: Breakup of Insulin Market by Class (in %)Figure 6 12: Canada: Insulin Market: Sales Share of Key Players (in %)Figure 6 13: Canada: Insulin Market Forecast (in Million US$), 2016 - 2020

9. Imarc www.imarcgroup.com Report Description and Highlights List of Tables Table 3 1: Diagnosis of Diabetes Table 4 1: Global: Diabetes Population Breakup by Country (in 000’s), 2015 & 2035Table 4 2: Canada: Overweight &Obesity Statistics, 2010, 2015 & 2020Table 4 3: Canada: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)Table 5 1: Canada: Total Prevalence & Number of Diabetes Patients*, 2008, 2015 & 2020Table 5 2: Canada (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020Table 5 3: Canada (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020Table 5 4: Canada (Male & Female): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2008, 2015 & 2020

10. Imarc www.imarcgroup.com Report Description and Highlights To buy the complete report or to get a free sample, please contact: IMARC Group Asia:Email: apac@imarcgroup.comPhone: +91-120-415-5099  IMARC Group North America:Email:  america@imarcgroup.comPhone: +1-631-791-1145 IMARC Group Europe, Middle East & Africa:Email: ema@imarcgroup.comPhone: +44-702-409-7331  To know more please visit: http://www.imarcgroup.com/canada-diabetes-market-report-forecast-2011-2016

11. Imarc www.imarcgroup.com Report Description and Highlights © 2015 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

12. Imarc www.imarcgroup.com FOR MORE DETAILS Visit us at : http://www.imarcgroup.com Stay With Us: • TELEPHONE: +91-120-4155099 E-MAIL: sales@imarcgroup.com